ObsEva Announces Positive Topline Results for Linzagolix
-Once daily linzagolix 200 mg with ABT met both co-primary efficacy objectives, demonstrating reductions in dysmenorrhea and non-menstrual pelvic pain...
Source: globenewswire.com
Page 2 - Primary Endpoints News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Primary Endpoints. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Primary Endpoints Today - Breaking & Trending Today
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial | Lifestyle Behaviors | JAMA
1. Jensen MD, Ryan DH, Apovian CM, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. 2. Heymsfield SB, van Mierlo CA, van der Knaap HC, Heo M, Frier HI. Weight management using a meal replacement...
Source: jamanetwork.com